Circ J 2009; 73: 508 -511 lthough drug-eluting stents (DES) have significantly decreased the incidence of restenosis and the need for repeat revascularization, restenosis still occurs. 1-10 Large-scale randomized trials 1-3 have demonstrated a high proportion of focal restenosis after DES implantation, but on the other hand, recent real-world registries have shown that a significant proportion of restenosis is non-focal when DES are used in unselected lesions. [4] [5] [6] [7] [8] The present study evaluated angiographic patterns of restenosis after sirolimuseluting stent (SES) implantation in real-world practice in Japan.
because, overall, there were lower numbers of non-focal restenotic lesions. Variables with P-value <0.1 between focal and non-focal restenoses were included in the multivariate model.
Results
Baseline, angiographic, and procedural characteristics are presented in Tables 1 and 2 . Quantitative coronary angiography results are shown in Table 3 . There were 98 focal (79.0%) and 26 non-focal restenoses (21.0%) (Figure 1 ). Focal intrastent restenosis was predominant (42.7%). Proximal edge restenosis occurred in 22 lesions (17.7%). The time to occurrence of restenosis was 10.5±6.6 months for focal restenosis and 11.4±5.7 months for non-focal restenosis (NS) . Multivariate analysis demonstrated diabetes mellitus as an independent predictor of non-focal restenosis ( Table 4) .
Discussion
The present study shows that, in Japanese patients, (1) focal restenosis is dominant after SES implantation; (2) focal intrastent restenosis is most frequent; (3) proximal edge restenosis occurs more frequently than distal edge restenosis; and (4) diabetes mellitus is associated with nonfocal restenosis after SES implantation.
Angiographic Restenosis Pattern After DES Implantation
Large-scale randomized trials 1-3 report a high proportion of focal restenosis after DES implantation. The SIRIUS study 1, 2 showed predominant focal angiographic restenosis after SES implantation (focal 83.9%, diffuse 3.2%, proliferative 6.5%, and occlusive 6.5%) and the TAXUS IV trial 3 demonstrated that focal restenosis was predominant after 12 showed that atherosclerosis defined as a maximal intimal thickness >0.5 mm was observed in 81.2% of coronary artery segments without angiographically significant stenosis. An intravascular ultrasound study of Japanese patients reported that atherosclerosis was observed in 63.2% and 63.9% of coronary artery segments with and without angiographically significant stenosis. 13 In addition, there is a difference in the dose of some drugs between Japanese and non-Japanese patients. 14 These might influence the results of the present study. Previous studies showed mechanisms of restenosis after DES implantation such as stent underexpansion, incomplete lesion coverage, stent fracture, non-uniform stent strut distribution, and disruption of the DES polymer. 10, [15] [16] [17] [18] [19] [20] The higher focal restenosis rate may be explained by higher usage of intravascular ultrasound in Japan to achieve optimal stent deployment. The complexity of target lesions may influence the incidence of focal restenosis. However, in the present study, lesion complexity, including quantitative coronary angiography results, was not less than that in previous registries. [4] [5] [6] [7] [8] Furthermore, routine angiographic follow-up might be associated with a higher incidence of focal restenosis. However, clinical presentation at follow-up angiography in the present study did not differ between patients with focal and non-focal restenosis.
SES Edge Restenosis
In the SIRIUS trial, most focal restenosis was proximal edge restenosis (proximal edge 5.5%, intrastent 3.2%, and distal edge 2.0%), 2 and a full-lesion coverage strategy was then adopted. 10 In the present study, proximal edge restenosis occurred in 22 (17.7%) of the 124 DES restenoses. Previous intravascular ultrasound studies demonstrated ubiquitous atherosclerosis, even in the angiographic reference segment. 12, 13, 21, 22 Thus, proximal edge restenosis may occur particularly when there is diffuse atherosclerosis in the angiographic reference segment. 22, 23 In contrast, distal edge restenosis is infrequent. An experimental study showed a higher drug concentration at the distal edge, 24 which may be associated with less restenosis.
Study Limitations
First of all, this was a retrospective analysis. Second, we did not elaborate the details of the lesions that underwent SES implantation. The restenosis rate in the present study was 9.5%, and previous studies of real-world practice in Japan showed restenosis rates of 4.0-14.0%. [25] [26] [27] Thus the present study seems to represent common practice in Japan. Third, re-restenosis and the second target lesion revascularization rates were not evaluated in the present study. All DES restenoses did not undergo target lesion revascularization. The clinical, angiographic, and procedural characteristics differ between the overall DES restenoses and those undergoing target lesion revascularization. 4, 5 Thus, we decided to report re-restenosis and the second target lesion revascularization rates after target lesion revascularization for DES restenoses as another study. 4, 5 
Conclusion
The present study shows that in real-world practice in Japan focal restenosis is dominant after SES implantation.
